» Sitio en español |» Contact
|Buscar

Our experience

your quality of life

Products

of renowned therapeutic action

Committed

to providing high quality products

Laboratorio Varifarma | Compromiso con la calidad

| Divisions

| News

New Clinical Evidence.

KYPROLIS®: Significantly improves overall survival in patients with relapsed multiple myeloma, demonstrated in two Phase 3 Studies.

» view more

| News

Launches:

Amgen has entrusted us with the representation of two new licences: Neupogen (filgrastim) and Neulastim (pegfilgrastim).

» view more
Copyright ©2017 - Laboratorio Varifarma S.A. |